retatrutide: Retatrutide Triple Agonist (GLP-1/GIP/GCG) Understanding the Retatrutide starting dose

Teladoc Health and Gifthealth partner to enhance access to Zepbound for members in the Comprehensive Weight Care Program

And I think the big question is to determine whether improvements in disease activity that we might see, whether they're entirely due to weight loss, or are there actually direct anti-inflammatory effects of these medications, which could be really interesting

For example, if a patient has recurrence of a previously resolved medical condition or if they gain more than 5% weight above their goal weight, then they are likely to continue to gain weight, says Lofton

NICE National Institute for Health and Care Excellence guidance on weight management